• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
Nairametrics
Home Sectors Health

NAFDAC raises alarm over killer cough syrup NATURECOLD

Chike Olisah by Chike Olisah
April 26, 2023
in Health
NAFDAC to Begin Clinical Trials of Malaria Vaccine Nationwide

Prof. Mojisola Adeyeye, DG NAFDAC

Share on FacebookShare on TwitterShare on Linkedin

Article Summary

  • NAFDAC has issued a warning to Nigerians about a cough syrup called NATURCOLD, which has caused the death of six children in Cameroon.
  • The cough syrup is not in NAFDAC’s database, and the agency is calling on importers, distributors, retailers, and consumers to exercise caution.
  • NAFDAC also advised people to avoid buying medicinal products from unauthorized sources such as roadside vendors and street hawkers.

The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted Nigerians about a killer cough syrup, identified as NATURCOLD.

This was made known on Wednesday by the Director-General of NAFDAC, Prof. Mojisola Adeyeye, who stated that the cough syrup has already caused the death of six children in Cameroon.

Adeyeye stated that the cough syrup was not in NAFDAC’s database, and advised importers, distributors, retailers, and consumers to exercise caution and vigilance within the supply chain.

MoreStories

See the owners of the largest private hospitals in Nigeria

See the owners of the largest private hospitals in Nigeria

April 9, 2026
FG debunks viral claim on free ‘revolutionary diabetes drug’ distribution 

FG begins talks with Airbus to acquire air ambulance helicopters

April 7, 2026

6 deaths recorded

Adeyeye explained that six children died at a health facility in the Cameroonian district of Fundong after taking the deadly syrup. She quoted Public Health delegates for the region who said the victims showed decreased kidney function after taking the syrup. 

Note that the syrup was not authorized for marketing in Cameroon and was bought from unauthorized sources. In the meantime, Cameroon’s Ministry of Public Health has issued a health alert over the substandard cough syrup.

To this end, Adeyeye has advised healthcare professionals and consumers in Nigeria to report any suspicion of the sale and use of substandard and falsified medicines to the nearest NAFDAC office. They can also use NAFDAC’s e-reporting channels: www.nafdac.gov.ng and pharmacovigilance@nafdac.gov.ng.

Combating fake drugs 

The NAFDAC boss called on importers, distributors, retailers, and consumers to avoid the importation, distribution, sale and consumption of substandard medication in the country. She said:

  • “All medical products must be obtained from authorized/licensed suppliers. The products’ authenticity and physical condition should be carefully checked.
  • “NAFDAC implores members of the public to desist from buying medicinal products from unauthorized sources such as roadside vendors and street hawkers.
  • “If you know anyone who has used this product, or suffered any adverse reaction after use, such person is advised to seek immediate medical advice from a qualified healthcare professional.’’

What you should know

Recall that NAFDAC had in October 2022 warned Nigerians against the use of four substandard cough syrups.

The products were listed as “Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold Syrup”.

NAFDAC had said all batches of the syrups should be considered unsafe, adding that the products are not registered by the agency and should, therefore, not be in circulation.


Add Nairametrics on Google News
Follow us for Breaking News and Market Intelligence.
Tags: NAFDAC
Chike Olisah

Chike Olisah

Chike was a banker with over 11 years experience in retail and commercial banking, risk management, treasury portfolio management and relationship management. He also acquired some experience in financial management and do have some special interest in investment analysis and personal finance. He had stints with financial institutions like the former Intercontinental Bank and Fidelity Bank.

Next Post
Elumelu’s HH Capital buys additional 19.34 million units of shares in UBA Plc

Elumelu confirms Transcorp Power to list in 5 years, responds to Otedola's 5.52% acquisition of Transcorp shares

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

rabafast

nairametrics




DUNS

Follow us on social media:

  • HOME
  • ABOUT NAIRAMETRICS
  • CONTACT US
  • DISCLAIMER
  • ADs DISCLAIMER
  • COPYRIGHT INFRINGEMENT

© 2026 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Social Media Auto Publish Powered By : XYZScripts.com
No Result
View All Result
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
  • Login
  • Sign Up

© 2026 Nairametrics